[1]LO M S,NEWBURGER J W.Role of intravenous immunoglobulin in the treatment of Kawasaki disease[J].Int J Rheum Dis,2018,21(1):64-69.DOI:10.1111/1756-185X.13220.
[2]SONG G,REN W,LIU Z,et al.Incomplete Kawasaki disease with coronary artery aneurysm and coronary sinus thrombus[J].Pediatr Cardiol,2015,36(5):1097-1099.DOI:10.1007/s00246-015-1144-2.
[3]MCCRINDLE B W,ROWLEY A H,NEWBURGER J W,et al.Diagnosis,treatment,and long-term management of Kawasaki disease:a scientific statement for health professionals from the American Heart Association[J].Circulation,2017,135(17):927-999.DOI:10.1161/CIR.0000000000000484.
[4]胡亚美,江载芳.实用儿科学[M].7版.北京:人民卫生出版社,2002:698-705.
[5]JAGGI P,WANG W,DVORCHIK I,et al.Patterns of fever in children after primary treatment for Kawasaki disease[J].Pediatr Infect Dis J,2015,34(12):1315-1318.DOI:10.1097/INF.0000000000000891.
[6]SUDO D,MONOBE Y,YASHIRO M,et al.Coronary artery lesions of incomplete Kawasaki disease:a nationwide survey in Japan[J].Eur J Pediatr,2012,171(9):651-656.DOI:10.1007/s00431-011-1630-3.
[7]唐孕佳,刘婷,严文华,等.不完全川崎病173例的临床分析[J].中华临床医师杂志(电子版),2015,18(9):3461-3464.DOI:10.3877/ cma.j.issn.1674-0785.2015.18.034.
TANG Y J,LIU T,YAN W H,et al.Clinincal analysis of 173 Cases of children with incomplete Kawasaki disease[J].Chinese Journal of Clinicians(Electronic Edition),2015,18(9):3461-3464.DOI:10.3877/ cma.j.issn.1674-0785.2015.18.034.
[8]TAKAHASHI T,SAKAKIBARA H,MORIKAWA Y,et al.Development of coronary artery lesions in indolent Kawasaki disease following initial spontaneous defervescence:a retrospective cohort study[J].Pediatr Rheumatol Online J,2015,13(1):1344-1352.DOI:10.1186/ s12969-015-0042-8.
[9]GARRIDO-GARCíA LM,CASTILLO-MOGUEL A,VáZQUEZ-RIVERA M,et al.Reaction of the BCG scar in the acute phase of Kawasaki disease in Mexican children[J].Pediatr Infect Dis J,2017,36(10):e237-241.DOI:10.1097/INF.0000000000001633.
[10]NOVAIS C,FORTUNATO F,BICHO A,et al.Bacillus Calmette-Guérin reactivation as a sign of incomplete Kawasaki disease[J].BMJ Case Rep,2016,43(3):3871-3875.DOI:10.1136/bcr-2015-213875.
[11]SINGH S,JINDAL A K,PILANIA R K.Diagnosis of Kawasaki disease[J].Int J Rheum Dis,2018,21(1):36-44.DOI:10.1111/1756-185X.13224.
[12]SON M B F,GAUVREAU K,KIM S,et al.Predicting coronary artery aneurysms in Kawasaki disease at a North American center:an assessment of baseline z scores[J].J Am Heart Assoc,2017,6(6):5378-5383.DOI:10.1161/JAHA.116.005378.
[13]HA K S,JANG G Y,LEE J,et al.Laboratory markers in incomplete Kawasaki disease according to coronary artery outcome[J].Korean Circ J,2018,48(4):287-295.DOI:10.4070/kcj.2017.0342.
[14]SAUNDANKAR J,YIM D,ITOTOH B,et al.The epidemiology and clinical features of Kawasaki disease in Australia[J].Pediatrics,2014,133(4):e1009-1014.DOI:10.1542/peds.2013-2936.
[15]TANG Y,YAN W,SUN L,et al.Kawasaki disease associated with Mycoplasma pneumoniae[J].Ital J Pediatr,2016,42(1):83-89.DOI:10.1186/s13052-016-0292-1.
[16]NANISHI E,NISHIO H,TAKADA H,et al.Clarithromycin plus intravenous immunoglobulin therapy can reduce the relapse rate of Kawasaki disease:a Phase 2,Open-Label,randomized control study[J].J Am Heart Assoc,2017,6(7):5370-5378.DOI:10.1161/JAHA.116.005370.
[17]黄国英,马晓静,黄敏,等.上海地区1998—2002年川崎病流行病学特征[J].中国循证儿科杂志,2006,1(1):8-13.DOI:10.3969/j.issn.1673-5501.2006.01.004.
HUANG G Y,MA X J,HUANG M,et al.Epidemiologic pictures of Kawasaki disease in Shanghai from 1998 through 2002[J].Chinese Journal of Evidence-Based Pediatrics,2006,1(1):8-13.DOI:10.3969/j.issn.1673-5501.2006.01.004.
[18]张晓梅,张宇,张圳,等.吉林省1999—2008年小儿川崎病流行病学调查[J].实用儿科临床杂志,2010,25(1):28-30.DOI:10.1007/s00246-011-0121-7.
ZHANG X M,ZHANG Y,ZHANG Z,et al.Study on epidemiology of Kawasaki disease in Jilin Province from 1999 to 2008[J].Journal of Applied Clinical Pediatrics,2010,25(1):28-30.DOI:10.1007/s00246-011-0121-7.